IceCure Medical Ltd
ICCM | NASDAQ
$2.01
+$0.06 (+3.08%)
Sep 22, 2026, 1:59 PM ET · Market open
Market Data
Market Cap $4.39M
Enterprise Value $-7.55M
Beta 0.45
Average Volume 3.38M
Shares Outstanding (Diluted) 3.09M
Shares Change YoY 57.76%
Institutional Ownership 4.42%
Exchange NASDAQ
ISIN IL0011224156
Price Performance
Price Change 1M -18.1%
Price Change 3M -68.1%
Price Change 6M -89.0%
Price Change YTD -89.7%
Price Change 1Y -93.9%
Price Change 3Y -89.3%
Price Change 5Y -99.3%
1M CAGR (ann.) -36.7%
1Y CAGR (ann.) -93.8%
5Y CAGR (ann.) -63.1%
All-Time CAGR -63.6%
Valuation
PE Ratio -0.29
Forward PE N/A
PEG Ratio -0.01
Forward PEG 0.01
PS Ratio 1.11
Forward PS 0.60
PB Ratio 0.37
P/FCF Ratio -0.27
P/Adj. FCF Ratio -0.25
P/OCF Ratio -0.37
EV/Sales -1.91
EV/EBIT 0.45
EV/EBITDA 0.46
EV/FCF 0.46
Earnings Yield -346.7%
FCF Yield -373.2%
Adj. FCF Yield -394.3%
Financial Health
Net Cash $12.03M
Total Debt $90K
Cash & Short-Term Investments $12.03M
Total Assets $17.71M
Current Ratio 2.87
Quick Ratio 2.44
Debt / Equity Ratio 0.01
Debt / EBITDA -0.01
Debt / FCF -0.01
OCF / Debt -181.33
Interest Coverage -139.87
Altman Z-Score -11.92
Piotroski F-Score 4
Margins & Profitability
Gross Profit Margin 36.1%
Operating Profit Margin -556.4%
EBITDA Margin -416.5%
Net Profit Margin -427.7%
FCF Margin -415.2%
Adj. FCF Margin -438.7%
SBC / Revenue 23.5%
SBC Impact (per share) -5.7%
Returns
Return on Assets -95.3%
Return on Equity -174.3%
Return on Invested Capital -183.2%
Return on Capital Employed -184.3%
Return on Tangible Assets -95.3%
Historical Growth (CAGR)
Revenue CAGR 3Y 7.0%
Revenue CAGR 5Y -0.7%
Revenue CAGR 10Y 18.1%
EPS CAGR 3Y 13.1%
EPS CAGR 5Y 16.2%
EPS CAGR 10Y 4.8%
FCF CAGR 3Y -18.4%
FCF CAGR 5Y 0.7%
FCF CAGR 10Y -20.9%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 3
EPS Growth Next 3Y 35.4%
Revenue Growth Next 3Y 125.0%
Earnings Date Nov 17, 2026
EPS Estimate (next Q) -$0.83
EPS Growth Est (next Q) -53.9%
Revenue Est (next Q) $876.5K
Revenue Growth Est (next Q) 3.1%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $1
Price Target Upside -48.7%
Cash Flow
Operating Cash Flow $-16.32M
Free Cash Flow $-16.39M
Adj. Free Cash Flow $-17.32M
FCF Per Share -$5.31
OCF Per Share -$5.29
OCF/S Ratio -413.5%
Income Statement
Revenue $3.95M
Gross Profit $1.43M
Operating Income $-21.96M
EBITDA $-16.44M
Net Income $-16.88M
EPS (Diluted) -$6.76
Revenue / Employee $58.04K
Profit / Employee $-248.24K
Employees 68
Add to Watchlist
Select watchlists to add or remove ICCM